RecruitingNCT07503067
Identifying Substance Use Consequences
Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials
Sponsor
Mclean Hospital
Enrollment
50 participants
Start Date
Feb 10, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- (1) ability to read and provide informed consent in English, and at least one of the following 2a) currently providing direct care to patients with substance use disorders, 2b) current or past treatment for an substance use disorder, or 2c) self-report of a close friend or family member who currently or previously received treatment for a substance use disorder.
Exclusion Criteria1
- \) major psychiatric or medical condition that would interfere with participation (e.g., acute psychosis, severe withdrawal); 2) current intoxication (positive breath alcohol test or behavioral evidence of other substance intoxication).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERnone, there is no intervention in this study
this is not an intervention study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07503067
Related Trials
California MEPS Hub
NCT074339853 locations
The Trans-Led Care Study
NCT068807051 location
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
NCT068037063 locations
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
NCT071993352 locations
Correctional Service of Canada Pilot Trial of Digital Substance Use Disorder Interventions (PROCESS)
NCT073422184 locations